| Literature DB >> 33570093 |
Michael C Holter1, Lauren T Hewitt1,2, Kenji J Nishimura1,2, Sara J Knowles1, George R Bjorklund1, Shiv Shah1, Noah R Fry1, Katherina P Rees1, Tanya A Gupta3, Carter W Daniels3,4, Guohui Li5, Steven Marsh6, David Michael Treiman6, Michael Foster Olive3, Trent R Anderson5, Federico Sanabria3, William D Snider7, Jason M Newbern1.
Abstract
Many developmental syndromes have been linked to genetic mutations that cause abnormal ERK/MAPK activity; however, the neuropathological effects of hyperactive signaling are not fully understood. Here, we examined whether hyperactivation of MEK1 modifies the development of GABAergic cortical interneurons (CINs), a heterogeneous population of inhibitory neurons necessary for cortical function. We show that GABAergic-neuron specific MEK1 hyperactivation in vivo leads to increased cleaved caspase-3 labeling in a subpopulation of immature neurons in the embryonic subpallial mantle zone. Adult mutants displayed a significant loss of parvalbumin (PV), but not somatostatin, expressing CINs and a reduction in perisomatic inhibitory synapses on excitatory neurons. Surviving mutant PV-CINs maintained a typical fast-spiking phenotype but showed signs of decreased intrinsic excitability that coincided with an increased risk of seizure-like phenotypes. In contrast to other mouse models of PV-CIN loss, we discovered a robust increase in the accumulation of perineuronal nets, an extracellular structure thought to restrict plasticity. Indeed, we found that mutants exhibited a significant impairment in the acquisition of behavioral response inhibition capacity. Overall, our data suggest PV-CIN development is particularly sensitive to hyperactive MEK1 signaling, which may underlie certain neurological deficits frequently observed in ERK/MAPK-linked syndromes.Entities:
Keywords: ADHD; ERK1/2; RASopathy; development; ganglionic eminence
Mesh:
Substances:
Year: 2021 PMID: 33570093 PMCID: PMC8325019 DOI: 10.1093/cercor/bhaa413
Source DB: PubMed Journal: Cereb Cortex ISSN: 1047-3211 Impact factor: 5.357